Ost-müük Takeda Pharmaceutical Company Limited - 4502 CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 24.12 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.010938% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.011284% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | JPY | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | Japan | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 4273.83 |
Avatud* | 4305.85 |
Aastane muutus* | 20.62% |
Päeva ulatus* | 4305.85 - 4350.74 |
52 nädala ulatus | 3,455.00-4,478.00 |
Keskmine maht (10 päeva) | 5.27M |
Keskmine maht (3 kuud) | 89.00M |
Turukapitalisatsioon | 6,786.47B |
P/E suhtarv | 24.37 |
Ringluses olevad aktsiad | 1.55B |
Tulu | 3,944.61B |
EPS | 175.97 |
Dividendid (% kasumist) | 4.19678 |
Beeta | 1.00 |
Järgmine tuluaruande kuupäev | May 11, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Mar 29, 2023 | 4334.78 | 37.80 | 0.88% | 4296.98 | 4339.77 | 4296.96 |
Mar 28, 2023 | 4273.83 | -40.00 | -0.93% | 4313.83 | 4320.92 | 4264.96 |
Mar 27, 2023 | 4277.82 | 6.38 | 0.15% | 4271.44 | 4289.80 | 4258.08 |
Mar 24, 2023 | 4254.99 | 11.77 | 0.28% | 4243.22 | 4267.86 | 4224.16 |
Mar 23, 2023 | 4252.60 | -32.31 | -0.75% | 4284.91 | 4286.90 | 4240.03 |
Mar 22, 2023 | 4358.72 | -55.75 | -1.26% | 4414.47 | 4414.47 | 4352.73 |
Mar 20, 2023 | 4283.82 | -61.23 | -1.41% | 4345.05 | 4347.74 | 4282.72 |
Mar 17, 2023 | 4369.09 | 34.51 | 0.80% | 4334.58 | 4382.66 | 4320.91 |
Mar 16, 2023 | 4273.94 | 6.88 | 0.16% | 4267.06 | 4292.79 | 4244.02 |
Mar 15, 2023 | 4332.19 | 30.12 | 0.70% | 4302.07 | 4332.19 | 4286.81 |
Mar 14, 2023 | 4265.46 | 32.02 | 0.76% | 4233.44 | 4293.29 | 4206.11 |
Mar 13, 2023 | 4279.92 | 5.49 | 0.13% | 4274.43 | 4290.30 | 4240.93 |
Mar 10, 2023 | 4335.78 | -9.97 | -0.23% | 4345.75 | 4354.23 | 4323.71 |
Mar 9, 2023 | 4388.64 | 54.76 | 1.26% | 4333.88 | 4390.64 | 4317.82 |
Mar 8, 2023 | 4323.81 | 31.92 | 0.74% | 4291.89 | 4329.90 | 4289.00 |
Mar 7, 2023 | 4289.10 | 19.16 | 0.45% | 4269.94 | 4292.89 | 4264.86 |
Mar 6, 2023 | 4260.97 | 21.94 | 0.52% | 4239.03 | 4269.45 | 4233.94 |
Mar 3, 2023 | 4237.04 | 46.28 | 1.10% | 4190.76 | 4252.40 | 4190.16 |
Mar 2, 2023 | 4172.11 | 5.49 | 0.13% | 4166.62 | 4188.56 | 4155.23 |
Mar 1, 2023 | 4165.22 | -5.09 | -0.12% | 4170.31 | 4191.16 | 4164.13 |
Takeda Pharmaceutical Company Limited Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 3569010 | 3197810 | 3291190 | 2097220 | 1770530 |
Tulu | 3569010 | 3197810 | 3291190 | 2097220 | 1770530 |
Kulud, Kokku | 1106850 | 994308 | 1089760 | 651729 | 495921 |
Brutokasum | 2462160 | 2203500 | 2201420 | 1445500 | 1274610 |
Kogu tegevuskulu | 3123810 | 2596860 | 3193730 | 1874650 | 1531000 |
Müük/Üldine/admin kulud, kokku | 886361 | 875663 | 964737 | 717599 | 628106 |
Uuringud ja arendus | 526087 | 455833 | 492381 | 368298 | 325441 |
Depreciation / Amortization | 472915 | 421864 | 455420 | 178617 | 122131 |
Ootamatud kulutused (tulu) | 100290 | -265230 | 189043 | -41201 | 28183 |
Other Operating Expenses, Total | 31309 | 114422 | 2384 | -2507 | -3907 |
Tulud majandustegevusest | 445198 | 600952 | 97459 | 222577 | 239528 |
Intressitulud (kulu), muud tulud, neto | -142628 | -234717 | -158213 | -94965 | -22323 |
Muud, neto | 1 | ||||
Netotulu enne makse | 302571 | 366235 | -60754 | 127612 | 217205 |
Netotulu pärast makse | 230166 | 376171 | 44290 | 135080 | 186708 |
Vähemuse intress | -107 | -166 | -49 | 112 | 178 |
Netotulu enne erikulusid | 230059 | 376005 | 44241 | 135192 | 186886 |
Netotulu | 230059 | 376005 | 44241 | 135192 | 186886 |
Arvestatav tulu, v a erikulud | 230059 | 376005 | 44241 | 135192 | 186886 |
Arvestatav tulu, koos erikuludega | 230059 | 376005 | 44241 | 135192 | 186886 |
Jaotamisele kuuluv netotulu | 230059 | 376005 | 44241 | 135192 | 186886 |
Keskmine jaotamisele kuuluv aktsia kohta | 1577.17 | 1573.54 | 1566.2 | 966.897 | 786.69 |
Jaotatav EPS, v a erakorralised kulud | 145.868 | 238.955 | 28.2473 | 139.82 | 237.56 |
Dividends per Share - Common Stock Primary Issue | 180 | 180 | 180 | 180 | 180 |
Jaotamisele kuuluv normaal-EPS | 194.24 | 129.394 | 106.703 | 112.123 | 268.355 |
Intressikulu (tulu) - neto majandustegevusest | 2112 | -64872 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kogutulu | 873289 | 901294 | 844819 | 949603 | 770274 |
Tulu | 873289 | 901294 | 844819 | 949603 | 770274 |
Kulud, Kokku | 308380 | 281404 | 275797 | 241264 | 253446 |
Brutokasum | 564909 | 619890 | 569022 | 708339 | 516828 |
Kogu tegevuskulu | 874908 | 784810 | 747392 | 701051 | 619734 |
Müük/Üldine/admin kulud, kokku | 223429 | 231078 | 212011 | 219843 | 234388 |
Uuringud ja arendus | 143628 | 128378 | 131600 | 122480 | 113289 |
Depreciation / Amortization | 149283 | 118087 | 102721 | 102824 | 114294 |
Ootamatud kulutused (tulu) | 33062 | 26767 | 27979 | 16751 | 29440 |
Other Operating Expenses, Total | 17126 | -904 | -2716 | -2111 | -125123 |
Tulud majandustegevusest | -1619 | 116484 | 97427 | 248552 | 150540 |
Intressitulud (kulu), muud tulud, neto | -52429 | -44291 | -35980 | -25574 | -19662 |
Netotulu enne makse | -54047 | 72193 | 61447 | 222978 | 130878 |
Netotulu pärast makse | -11375 | 57820 | 45995 | 137726 | 197144 |
Vähemuse intress | 17 | -51 | -31 | -43 | -46 |
Netotulu enne erikulusid | -11358 | 57769 | 45964 | 137683 | 197098 |
Netotulu | -11358 | 57769 | 45964 | 137683 | 197098 |
Arvestatav tulu, v a erikulud | -11358 | 57770 | 45964 | 137684 | 197098 |
Arvestatav tulu, koos erikuludega | -11358 | 57770 | 45964 | 137684 | 197098 |
Jaotamisele kuuluv netotulu | -11358 | 57770 | 45964 | 137684 | 197098 |
Keskmine jaotamisele kuuluv aktsia kohta | 1553.81 | 1574.97 | 1580.42 | 1574.43 | 1574.48 |
Jaotatav EPS, v a erakorralised kulud | -7.30976 | 36.68 | 29.0834 | 87.4503 | 125.183 |
Dividends per Share - Common Stock Primary Issue | 90 | 0 | 90 | 0 | 90 |
Jaotamisele kuuluv normaal-EPS | 6.52092 | 50.2916 | 42.335 | 94.0219 | 137.337 |
Total Adjustments to Net Income | 1 | 0 | 1 | ||
Muud, neto | 1 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 2593640 | 2712890 | 2469430 | 2993040 | 1078810 |
Raha ja lühiajalised investeeringud | 875000 | 1002820 | 653436 | 725819 | 375186 |
Raha ja ekvivalendid | 389058 | 335027 | 188640 | 462890 | 243324 |
Lühiajalised investeeringud | 485942 | 667793 | 464796 | 262929 | 131862 |
Laekumata arved, neto | 724377 | 812714 | 784921 | 749119 | 428792 |
Accounts Receivable - Trade, Net | 617518 | 707487 | 670708 | 657681 | 360833 |
Total Inventory | 853167 | 753881 | 759599 | 919670 | 212944 |
Other Current Assets, Total | 141098 | 143478 | 271476 | 598429 | 61886 |
Total Assets | 13178000 | 12912300 | 12821100 | 13792800 | 4106460 |
Property/Plant/Equipment, Total - Net | 1582800 | 1453920 | 1386370 | 1331930 | 536801 |
Property/Plant/Equipment, Total - Gross | 2453010 | 2191740 | 2084120 | 1971520 | 1191400 |
Accumulated Depreciation, Total | -870208 | -737818 | -697754 | -639591 | -654597 |
Goodwill, Net | 4407750 | 4033920 | 4012530 | 4240250 | 1029250 |
Intangibles, Net | 3818540 | 3909110 | 4171360 | 4751170 | 1014260 |
Long Term Investments | 330133 | 348350 | 369455 | 299922 | 304385 |
Other Long Term Assets, Total | 445150 | 454110 | 411948 | 176463 | 142957 |
Total Current Liabilities | 2145730 | 1773180 | 2175900 | 2553050 | 737509 |
Accounts Payable | 295933 | 232105 | 211627 | 212348 | 133705 |
Notes Payable/Short Term Debt | 285 | 69 | 5014 | 500002 | 18 |
Current Port. of LT Debt/Capital Leases | 203708 | 22084 | 581803 | 484944 | |
Other Current Liabilities, Total | 1645800 | 1518920 | 1377450 | 1355760 | 603786 |
Total Liabilities | 7495000 | 7739260 | 8097610 | 8610790 | 2109040 |
Total Long Term Debt | 4141420 | 4613220 | 4506490 | 4766000 | 985644 |
Long Term Debt | 4141420 | 4613220 | 4506490 | 4766000 | 985644 |
Deferred Income Tax | 473145 | 576542 | 765079 | 783356 | 90725 |
Minority Interest | 504 | 4140 | 4003 | 4006 | 19985 |
Other Liabilities, Total | 734202 | 772180 | 646144 | 504372 | 275176 |
Total Equity | 5683020 | 5173040 | 4723480 | 5181980 | 1997420 |
Common Stock | 1676260 | 1668140 | 1668120 | 1643580 | 77914 |
Additional Paid-In Capital | 1708870 | 1688420 | 1680290 | 1650230 | 90740 |
Retained Earnings (Accumulated Deficit) | 1479720 | 1509910 | 1369970 | 1595430 | 1557310 |
Treasury Stock - Common | -116007 | -59552 | -87463 | -57142 | -74373 |
Unrealized Gain (Loss) | 22068 | 41983 | 22891 | 46380 | 73037 |
Other Equity, Total | 912106 | 324131 | 69673 | 303499 | 272799 |
Total Liabilities & Shareholders’ Equity | 13178000 | 12912300 | 12821100 | 13792800 | 4106460 |
Total Common Shares Outstanding | 1550.36 | 1563.36 | 1557.77 | 1554.78 | 781.309 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 2593640 | 2477890 | 2456350 | 2476460 | 2712890 |
Raha ja lühiajalised investeeringud | 875000 | 751896 | 633623 | 684850 | 1002820 |
Raha ja ekvivalendid | 849695 | 724341 | 607881 | 654920 | 966222 |
Lühiajalised investeeringud | 25305 | 27555 | 25742 | 29930 | 36598 |
Laekumata arved, neto | 724377 | 756117 | 887295 | 858957 | 812714 |
Accounts Receivable - Trade, Net | 696644 | 715515 | 843625 | 827253 | 783091 |
Total Inventory | 853167 | 811324 | 783476 | 779148 | 753881 |
Other Current Assets, Total | 141098 | 158556 | 151959 | 153503 | 143478 |
Total Assets | 13178000 | 12698500 | 12560300 | 12657200 | 12912300 |
Property/Plant/Equipment, Total - Net | 1582800 | 1493590 | 1459920 | 1452170 | 1453920 |
Goodwill, Net | 4407750 | 4167990 | 4078370 | 4058940 | 4033920 |
Intangibles, Net | 3818540 | 3791880 | 3783680 | 3856430 | 3909110 |
Long Term Investments | 330133 | 334812 | 352091 | 374659 | 348350 |
Other Long Term Assets, Total | 445150 | 432359 | 429864 | 438578 | 454110 |
Total Current Liabilities | 2145730 | 1809250 | 1918750 | 1706780 | 1773180 |
Accounts Payable | 516297 | 351185 | 336600 | 320645 | 343838 |
Notes Payable/Short Term Debt | 285 | 0 | 0 | 0 | 69 |
Current Port. of LT Debt/Capital Leases | 203708 | 122936 | 214886 | 24272 | 22084 |
Other Current Liabilities, Total | 1425440 | 1335130 | 1367260 | 1361860 | 1407180 |
Total Liabilities | 7495000 | 7367190 | 7236340 | 7418980 | 7739260 |
Total Long Term Debt | 4141420 | 4231940 | 4016470 | 4381590 | 4613220 |
Long Term Debt | 4141420 | 4231940 | 4016470 | 4381590 | 4613220 |
Deferred Income Tax | 473145 | 589481 | 576738 | 578065 | 576542 |
Minority Interest | 504 | 493 | 426 | 385 | 4140 |
Other Liabilities, Total | 734202 | 736023 | 723951 | 752155 | 772180 |
Total Equity | 5683020 | 5331330 | 5323940 | 5238260 | 5173040 |
Common Stock | 1676260 | 1676260 | 1676260 | 1669120 | 1668140 |
Additional Paid-In Capital | 1708870 | 1697560 | 1686490 | 1682500 | 1688420 |
Retained Earnings (Accumulated Deficit) | 1479720 | 1466930 | 1551150 | 1503810 | 1509910 |
Treasury Stock - Common | -116007 | -91013 | -41037 | -42344 | -59552 |
Unrealized Gain (Loss) | 22068 | 31196 | 57646 | 41983 | |
Other Equity, Total | 912106 | 550395 | 451066 | 367516 | 324131 |
Total Liabilities & Shareholders’ Equity | 13178000 | 12698500 | 12560300 | 12657200 | 12912300 |
Total Common Shares Outstanding | 1550.36 | 1557.49 | 1572.83 | 1568.66 | 1563.36 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | 230166 | 376171 | 44290 | 109014 | 186708 |
Raha majandustegevusest | 1123100 | 1010930 | 670381 | 328301 | 399200 |
Raha majandustegevusest | 583151 | 559671 | 583649 | 272446 | 182127 |
Mittelikviidsed varad | 252109 | 12308 | 172928 | 39061 | -43306 |
Cash Taxes Paid | 140423 | 201687 | 226768 | 44909 | 29883 |
Makstud intressid | 108207 | 107350 | 127211 | 34914 | 8365 |
Muutused tööjõus | 57679 | 62781 | -130486 | -92220 | 73671 |
Tulu investeeringutelt | -198125 | 393530 | 292119 | -2835700 | -93342 |
Kapitalikulutused | -186037 | -236468 | -217710 | -134114 | -128262 |
Muud rahavood investeeringutelt, kokku | -12088 | 629998 | 509829 | -2701580 | 34920 |
Rahavood investeeringutelt | -1070260 | -1088350 | -1005210 | 2946240 | -326226 |
Rahavoogudesse investeerimine | -108592 | -142352 | -132804 | -71143 | -15099 |
Total Cash Dividends Paid | -283665 | -283357 | -282582 | -142952 | -141893 |
Aktsiate emiteerimine (tagasiost), neto | -77531 | -2141 | -3737 | -1172 | -18756 |
Laenu väljastamine (kustutamine), neto | -600477 | -660504 | -586090 | 3161500 | -150478 |
Muutused valuutakursside kõikumisest | 28758 | 12501 | -21766 | -31269 | -4565 |
Rahaline kogumuutus | -116527 | 328608 | -64479 | 407571 | -24933 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 230166 | 241541 | 183721 | 137726 | 376171 |
Cash From Operating Activities | 1123100 | 747521 | 400011 | 166858 | 1010930 |
Cash From Operating Activities | 583151 | 430877 | 283595 | 142948 | 559671 |
Non-Cash Items | 252109 | 187026 | 112596 | 53003 | 12308 |
Cash Taxes Paid | 140423 | 101086 | 73872 | 35902 | 201687 |
Cash Interest Paid | 108207 | 84917 | 52668 | 23218 | 107350 |
Changes in Working Capital | 57679 | -111923 | -179901 | -166819 | 62781 |
Cash From Investing Activities | -198125 | -172487 | -103349 | -70445 | 393530 |
Capital Expenditures | -186037 | -134214 | -85783 | -42292 | -236468 |
Other Investing Cash Flow Items, Total | -12088 | -38273 | -17566 | -28153 | 629998 |
Cash From Financing Activities | -1070260 | -826465 | -658405 | -411038 | -1088350 |
Financing Cash Flow Items | -108592 | -85284 | -52681 | -23218 | -142352 |
Total Cash Dividends Paid | -283665 | -273024 | -141573 | -132032 | -283357 |
Issuance (Retirement) of Stock, Net | -77531 | -52538 | -2542 | -2542 | -2141 |
Issuance (Retirement) of Debt, Net | -600477 | -415619 | -461609 | -253246 | -660504 |
Foreign Exchange Effects | 28758 | 9549 | 3402 | 3324 | 12501 |
Net Change in Cash | -116527 | -241882 | -358341 | -311301 | 328608 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Nomura Asset Management Co., Ltd. | Investment Advisor | 4.1084 | 65007007 | -76000 | 2023-02-28 | LOW |
Sumitomo Mitsui Trust Asset Management Co., Ltd. | Investment Advisor | 3.8571 | 61030834 | 60943076 | 2022-11-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6692 | 42234586 | 57700 | 2023-02-28 | LOW |
JPMorgan Securities Japan Co., Ltd. | Research Firm | 2.3848 | 37735000 | 13609000 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.2293 | 35273592 | -840008 | 2023-02-28 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 2.0544 | 32507000 | 2470629 | 2022-11-30 | LOW |
Daiwa Asset Management Co., Ltd. | Investment Advisor | 1.8823 | 29784238 | -48400 | 2023-02-28 | LOW |
Nippon Life Insurance Company | Insurance Company | 1.861 | 29447000 | -2377000 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 1.8554 | 29358500 | 18800 | 2023-01-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5239 | 24113047 | 1171849 | 2022-12-31 | LOW |
Takeda Science Foundation | Corporation | 1.132 | 17912000 | 0 | 2022-09-30 | LOW |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | Investment Advisor | 0.778 | 12309837 | -65791 | 2023-02-28 | LOW |
CPP Investment Board | Pension Fund | 0.7341 | 11616000 | 7985000 | 2022-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7089 | 11216737 | 13283 | 2023-02-28 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5202 | 8230678 | 47200 | 2023-02-28 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.5143 | 8137797 | 8137597 | 2021-06-30 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 0.4559 | 7213600 | 0 | 2023-01-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4421 | 6994953 | 16400 | 2023-02-28 | LOW |
California Public Employees' Retirement System | Pension Fund | 0.4418 | 6989926 | 722900 | 2022-06-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.4359 | 6897836 | -59516 | 2023-02-28 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Takeda Pharmaceutical Company Limited Company profile
Ettevõttest Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited on Jaapanis asuv ettevõte, mis tegeleb peamiselt farmaatsiatööstusega. Ettevõte tegeleb farmaatsiatoodete, üldmeditsiinitoodete, kvaasiravimite ja tervishoiutoodete uurimise, arendamise, tootmise ja müügiga Jaapanis ja välismaal. Ettevõtte teadus- ja arendustegevus on koondunud nelja valdkonda: onkoloogia (vähk), seedetrakti haigused, haruldased haigused ja neuroloogia (neuropsühhiaatrilised haigused) ning kaks äriüksust: plasmafraktsioonitooted ja vaktsiinid. Ettevõte tegeleb torujuhtmete täiustamisega peamiselt Jaapanis ja Ameerika Ühendriikides asuvates uurimis- ja arenduskeskustes.
Industry: | Pharmaceuticals (NEC) |
4階
日本橋本町二丁目1番1号
CHUO-KU
TOKYO-TO 103-8668
JP
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com